Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
How Bispecific Antibodies Are Reshaping Cancer Care
Experts discuss how the availability of bispecific therapies has influenced treatment paradigms in oncology and how bispecifics fit into current treatment algorithms for hematologic malignancies and solid tumors.
EP: 1.Expanding Horizons: The Present and Future of Bispecific Antibodies Across Oncology
EP: 2.Revolutionizing Cancer Treatment: Key Bispecific Antibody Approvals
Now Viewing
EP: 3.How Bispecific Antibodies Are Reshaping Cancer Care
EP: 4.Optimizing Bispecific Antibody Use: Opportunities to Broaden Patient Access
EP: 5.Integrating Bispecific Antibodies in Community Oncology: Benefits and Considerations
EP: 6.Overcoming Key Operational Challenges in Integrating Bispecific Therapies
EP: 7.Partnerships in Bispecific Therapy: A Model for Supporting Community Oncology
EP: 8.Managing Complexity: Standardizing Workflows for Multiple Bispecific Therapies
EP: 9.Standardizing CRS Management and Ensuring Smooth Transitions of Care in Bispecific Therapy
EP: 10.Optimizing Bispecific Antibody Administration With EHR and Technology Solutions
EP: 11.Addressing Resource and Bandwidth Challenges in Bispecific Antibody Administration
EP: 12.Payer and Reimbursement Considerations for Bispecific Therapies
EP: 13.Emerging Therapeutic Areas for Bispecific Antibodies
EP: 14.Incorporating Bispecific Antibodies Earlier in Treatment and Improving Access in Underserved Communities
EP: 15.Future Breakthroughs: What’s Next for Bispecific Antibodies in Oncology?
Video content above is prompted by the following:
- How has the availability of bispecific therapies influenced treatment paradigms in oncology?
- How do bispecifics fit into current treatment algorithms for hematologic malignancies and solid tumors?
Related Videos
Related Content
